Telix Pharmaceuticals Ltd. (TLX)
11.12
+0.34
(+3.15%)
USD |
NASDAQ |
Oct 07, 16:00
10.70
-0.42
(-3.78%)
Pre-Market: 07:59
Telix Pharmaceuticals Price : 11.12 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 11.01 | 11.14 | 11.00 | 11.12 | 817437.0 |
| Oct 06, 2026 | 10.96 | 10.96 | 10.73 | 10.78 | 235101.0 |
| Oct 05, 2026 | 10.80 | 10.91 | 10.79 | 10.88 | 235286.0 |
| Oct 02, 2026 | 10.64 | 10.64 | 10.45 | 10.55 | 299612.0 |
| Oct 01, 2026 | 10.90 | 10.94 | 10.72 | 10.72 | 201808.0 |
| Sep 30, 2026 | 11.23 | 11.23 | 10.93 | 10.97 | 344245.0 |
| Sep 29, 2026 | 11.64 | 11.64 | 11.23 | 11.34 | 428308.0 |
| Sep 28, 2026 | 11.44 | 11.69 | 11.35 | 11.62 | 851000.0 |
| Sep 25, 2026 | 11.30 | 11.45 | 11.28 | 11.45 | 409202.0 |
| Sep 24, 2026 | 11.29 | 11.38 | 11.11 | 11.31 | 830287.0 |
| Sep 23, 2026 | 11.41 | 11.45 | 11.20 | 11.27 | 464894.0 |
| Sep 22, 2026 | 11.93 | 12.10 | 11.83 | 11.95 | 613710.0 |
| Sep 21, 2026 | 11.24 | 11.60 | 10.76 | 11.31 | 865930.0 |
| Sep 18, 2026 | 12.73 | 12.80 | 12.55 | 12.59 | 187397.0 |
| Sep 17, 2026 | 12.45 | 12.72 | 12.38 | 12.50 | 412913.0 |
| Sep 16, 2026 | 12.22 | 12.22 | 11.62 | 11.83 | 642226.0 |
| Sep 15, 2026 | 12.62 | 13.11 | 12.59 | 12.83 | 1.079M |
| Sep 14, 2026 | 12.20 | 12.23 | 11.67 | 11.78 | 630491.0 |
| Sep 11, 2026 | 11.75 | 11.75 | 11.20 | 11.29 | 415338.0 |
| Sep 10, 2026 | 12.10 | 12.20 | 11.88 | 11.90 | 337791.0 |
| Sep 09, 2026 | 12.08 | 12.48 | 11.96 | 12.34 | 548309.0 |
| Sep 08, 2026 | 12.07 | 12.21 | 11.98 | 11.98 | 336394.0 |
| Sep 04, 2026 | 11.84 | 11.95 | 11.84 | 11.94 | 142007.0 |
| Sep 03, 2026 | 11.70 | 11.78 | 11.61 | 11.74 | 139775.0 |
| Sep 02, 2026 | 11.40 | 11.79 | 11.38 | 11.45 | 239369.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mesoblast Ltd. | 13.94 |
| Immutep Ltd. | 4.06 |
| CSL Ltd. | 31.51 |
| Ceryvyn Therapeutics Ltd. | 0.026 |
| Propanc Biopharma, Inc. | 0.4987 |
Price Related Metrics
| PE Ratio | 118.93 |
| PS Ratio | 4.331 |
| Price to Book Value | 31.44 |
| Earnings Yield | 0.84% |
| Market Cap | 3.778B |
| Normalized PE Ratio | 203.66 |